Azithromycin vs Durvalumab

## Azithromycin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Azithromycin** and **Durvalumab**.

## Mechanism of Action

**Azithromycin**: Binds 50S ribosomal subunit, inhibiting bacterial protein synthesis.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Azithromycin — 68 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Azithromycin — C38H72N2O12; Durvalumab — N/A.

**Molecular Weight**: Azithromycin — 748.9840 g/mol; Durvalumab — N/A.

**Type**: Azithromycin — Small molecule; Durvalumab — Antibody.